baber/WOPTO huggingface dataset:
Patent DE-69627943-D1 (DE)
Inventor: ONO TAKAYUKI
IPC: D04H1/45
Filed: 1996-08-01
Granted: 2003-06-12
Abstract: An ink absorber is housed inside a housing of an ink tank and is capable of retaining ink. The ink absorber has an outer surface equal to or corresponding to a shape of an internal surface of the housing and is made of a fiber material obtained by compressing a fiber body and thermally molding at least a surface thereof. An ink tank is comprised of the ink absorber and the housing. An ink jet cartridge is comprised of the ink tank and a print head. A process for producing the ink tank comprises a first molding step of molding a continuous fiber aggregate of a rod shape or a plate shape with elasticity, a step of cutting the fiber aggregate thus molded to form a fiber body, a second molding step of subjecting the fiber body to compression and thermal molding so as to provide the fiber body with an outer surface corresponding to a shape of the inside of the housing, thus forming an ink absorber and a step of inserting the ink absorber into the inside of the housing. <IMAGE>
Patent DE-69629884-D1 (DE)
Inventor: VANCE ARLENE M
IPC: G06Q10/00
Filed: 1996-09-06
Granted: 2003-10-16
Abstract: A system for corporate travel planning, expense reporting and travel management comprises a computerised reservation system (30), a relational database server computer (18) adapted to be linked to the reservation system (30) and a travel planning, expense reporting and travel management system (38) resident on a personal computer (22) and providing a graphical user interface for communication between a user of the personal computer, the system (38) and the relational database server (18). <IMAGE>A system for corporate travel planning, expense reporting and travel management comprises a computerised reservation system (30), a relational database server computer (18) adapted to be linked to the reservation system (30) and a travel planning, expense reporting and travel management system (38) resident on a personal computer (22) and providing a graphical user interface for communication between a user of the personal computer, the system (38) and the relational database server (18). <IMAGE>
Patent DE-69634483-D1 (DE)
Inventor: DELUCA F
IPC: A61P3/02
Filed: 1996-07-09
Granted: 2005-04-21
Abstract: The 19-nor-vitamin D analogs, and particularly 19-nor-1 alpha ,25-dihydroxyvitamin D2, possess low calcemic and phosphatemic activity while also having the ability to suppress parathyroid hormone (PTH) production. The suppressive effect on PTH secretion of these 19-nor analogs without significant changes in serum calcium or serum phosphorus make them ideal tools for the treatment of secondary hyperparathyroidism in patients having kidney disorders.
Patent DE-69635418-D1 (DE)
Inventor: JENCZEWSKI JOHN
IPC: C07D201/12
Filed: 1996-08-05
Granted: 2005-12-15
Abstract: A process for recovering monomer from multi-component waste material that includes a hydrolyzable polymer, includes contacting the multi-component waste material with water and subjecting the resulting mixture to heat and pressure to form a liquid aqueous portion and a water insoluble portion. The liquid aqueous portion mainly includes depolymerization products of the hydrolyzable polymer, and the water insoluble portion mainly includes components other than the depolymerization products. This mixture is cooled and the liquid aqueous portion and the water insoluble portion are separated. Monomer that formed the hydrolyzable polymer is recovered from the liquid aqueous solution.
Patent DE-69638100-D1 (DE)
Inventor: QUARFORDT PER ULF
IPC: E02F9/28
Filed: 1996-11-15
Granted: 2010-01-28
Abstract: At their lower edge (6) excavators are provided with a tooth arrangement consisting of two parts (1 and 2), one part (2) being attached to the bucket (6) and the other part (1) being exchangeable. The two parts (1 and 2) are held together by means of a male and female relationship and a transverse aperture (3 and 25) with a locking body (4). When the exchangeable part (1) becomes worn it may start to become unstable. The object of the present invention is to eliminate this drawback and this is achieved in that the locking body (4) comprises two opposing flat surfaces, provided with one or more spacers (15-20) intended to restrict approach of the two surfaces towards each other.
Patent DE-69700179-D1 (DE)
Inventor: NIELSEN HENRIK
IPC: A47J31/44
Filed: 1997-06-04
Granted: 1999-05-20
Abstract: The dripped coffee maker has a conical filter (20) that is filled with ground coffee. The level of ground coffee in place in the filter cone is indicated on an external graduated scale (49) by a moving pointer (35). The moving pointer is operated by a mechanical coupling (47) from a four-bar parallelogram linkage (33). The four-bar linkage is displaced by the weight of the cone as it is filled with ground coffee, causing the pointer link, which is an extension of one side of the four-bar linkage, to be displaced angularly and to thus move the pointer along the external scale.
Patent DE-69704229-D1 (DE)
Inventor: MAULDIN SCOTT CARL
IPC: C07C251/42
Filed: 1997-05-02
Granted: 2001-04-19
Abstract: The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
Patent DE-69705504-D1 (DE)
Inventor: HASSLER G
IPC: D21H17/29
Filed: 1997-03-14
Granted: 2001-08-09
Abstract: PCT No. PCT/EP97/01308 Sec. 371 Date Aug. 19, 1998 Sec. 102(e) Date Aug. 19, 1998 PCT Filed Mar. 14, 1997 PCT Pub. No. WO97/35068 PCT Pub. Date Sep. 25, 1997Disclosed are a paper size consisting essentially of a) alkyl ketene dimer and/or alkenyl succinic acid anhydride; b) degraded, liquid cationic starch having a cationic charge density of 0.5 to 3.5 meqv/g, a degree of substitution of more than 0.1 and a viscosity of less than 10000 cps (30% by weight solution in water at 25 DEG  C.); and c) water, and a process for making paper products in which this paper size is added to the pulp. The invention allows the production of AKD and/or ASA sizes on-site in paper plants using simple mixing equipment.
Patent DE-69709422-D1 (DE)
Inventor: MIKI KAZUKI
IPC: H01J23/12
Filed: 1997-03-17
Granted: 2002-02-07
Abstract: A magnetron including: an anode cylinder (1) in which a plurality of vanes (2) are formed, a filament (3) provided at a center of the anode cylinder (11), a top hat (4) which supports an upper end of the filament (3), a top lead (6) for connecting the top hat (4) at an upper end of the top lead (6), an end hat (5) which supports a lower end of the filament (3), an end lead (7) for connecting the end hat (5) at an upper end of the end lead (7), a stem metal (11) hermetically sealed at an open end of the anode cylinder (1) through a pole piece (10), and a choke (12) disposed inside the stem metal (11), wherein the choke (12) is disposed approximately at a distance (C1) of one wavelength of a predetermined high frequency from the top hat (4) along of the top lead (6). It is possible to suppress generation of undesired high frequency, especially of the fifth harmonic, from the input portion. <IMAGE>
Patent DE-69710564-D1 (DE)
Inventor: COMBAS CHRISTIAN
IPC: E05B5/00
Filed: 1997-11-21
Granted: 2002-03-28
Abstract: The handle comprises a box (29) which is attached to a panel and a flap (30) which is mounted to pivot within the box. The flap pivots between a retracted position when it lies flat against the box to which is it attached and a deployed position when it stands out from the box at right angles. Between the box and the flap there are two distinct hinge regions (Z). For each there is a first shaped peg turning within a guide aperture and a second peg running along a curved slot. The first hinge allows the flap to pivot upwards about an axis near to its top edge, while the second hinge allows the flap to pivot downwards about an axis near to its bottom edge. In each case one hinge forms the pivot whilst the other hinge is released to allow the flap to move.
Patent DE-69712913-D1 (DE)
Inventor: KILBERT K
IPC: B22D17/00
Filed: 1997-07-30
Granted: 2002-07-04
Abstract: The present invention reveals an improvement in an apparatus for injection molding a metallic material having dendritic properties. In the improvement, a sub-ring is placed under a piston ring on a sliding seal ring of a non-return valve assembly. The sub-ring seals the pressure and metal flow in the apparatus, virtually eliminates piston ring leakage and extends the usable life of the non-return valve assembly.
Patent DE-69716685-D1 (DE)
Inventor: ELLIS ERNEST W
IPC: B41N1/00
Filed: 1997-08-19
Granted: 2002-12-05
Abstract: Constructions useful as lithographic printing plates include metallic inorganic layers exhibiting both hydrophilicity and substantial durability at very thin application levels. These materials ablatively absorb imaging radiation, thereby facilitating direct imaging without chemical development. They can also be used to form optical interference structures which, in addition to providing color, likewise absorb imaging radiation and ablate in response to imaging pulses. <IMAGE>
Patent DE-69717293-D1 (DE)
Inventor: HO BERT
IPC: A61P29/00
Filed: 1997-09-17
Granted: 2003-01-02
Abstract: The present invention relates to novel formulations of corticotropin releasing factor (CRF) having improved stability during storage over extended periods of time as liquids, which retain significant pharmaceutical activity during such storage and/or which are physiologically compatible. The formulations of the present invention comprise (a) a pharmaceutically effective concentration of CRF, (b) a buffer to maintain the pH of the formulation between about 2.0 to about 5.0 or about 6.0 to about 9.0 when in liquid form and (c) an alcohol such as mannitol, sorbitol, methanol, glycerol, or the like. Other aspects of the present invention involve addition of various other components to the formulations described herein for the purpose of decreasing the rate of degradation of the CRF peptide or increasing its solubility in solution. Finally, the present invention is further directed to methods for preparing such novel pharmaceutical formulations of CRF and methods of using those formulations to reduce inflammation and edema in mammals.
Patent DE-69719975-D1 (DE)
Inventor: VALDEMARSSON STEFAN
IPC: H01F29/00
Filed: 1997-05-16
Granted: 2003-04-24
Abstract: PCT No. PCT/SE97/00802 Sec. 371 Date Nov. 12, 1998 Sec. 102(e) Date Nov. 12, 1998 PCT Filed May 16, 1997 PCT Pub. No. WO97/44795 PCT Pub. Date Nov. 27, 1997A controllable inductor comprises at least a tubular core, a main winding (1) surrounding the core and a control winding (3) passing substantially axially through the core. It is adapted for connection to a three phase alternating current network and has for this sake for each phase (14-16) a main winding (1) for connection to the phase, a core and a control winding, and the control windings of the three phases are electrically connected in series to each other.
Patent DE-69720769-D1 (DE)
Inventor: SHIMIZU YASUHIKO
IPC: A61L31/04
Filed: 1997-11-19
Granted: 2003-05-15
Abstract: The present invention offers an artificial tube for nerve which can remain in the body until the nerve regenerates while does not remain as a foreign body in the body following nerve regeneration, and which induces axons regenerated from severed nerve stumps, can promote infiltration of blood capillaries from the body and regeneration of nerve tissue. The present invention comprises a tube 10 or 20 having coating layers 12, 13 or 22, 23 composed of gelatin or collagen on the inner and outer surfaces of a tube 11 or 21 composed of a material being biodegradable and absorbable in vivo, and a collagen body 30 or 40 having cavities 32, 33 or 41 which pass through said tube so as to be substantially parallel to the axis of said tube; wherein, said cavities are filled with a matrix gel.
Patent DE-69724103-D1 (DE)
Inventor: BLOMDELL PETER
IPC: A47C7/40
Filed: 1997-02-28
Granted: 2003-09-18
Abstract: PCT No. PCT/SE97/00354 Sec. 371 Date Aug. 28, 1998 Sec. 102(e) Date Aug. 28, 1998 PCT Filed Feb. 28, 1997 PCT Pub. No. WO97/31800 PCT Pub. Date Sep. 4, 1997A method for safe restraint of occupants in a crashing vehicle using safety belts, and a double tube frame construction vehicle seat. In a crash the kinetic energy of the occupant is restrained by the belt and by the cooperating resiliently deformable double tube frame construction in such a way that, at a moderate load, the upper portion of this double tube frame construction will move resiliently, but with a bigger load a permanent deformation will be the result. The device includes a seat frame with a seat portion and a back rest portion being made of a parallel tube frame having two tubes arranged above/under and forward/behind, at the seat portion and at the back rest portion respectively, up to a height at the breast of the occupant. The tubes are twisted above this height to a position side by side. Reinforcing, deformable form plates are rigidly arranged between the parallel tubes at least at the seat portion and at the lower portion of the back rest portion.
Patent DE-69724487-D1 (DE)
Inventor: BACKUS JOHN WESLEY
IPC: C12Q1/68
Filed: 1997-03-11
Granted: 2003-10-09
Abstract: The present invention relates to a method for amplifying and detecting a target nucleic acid. The method comprising contacting a sample suspected of containing the target nucleic acid with a thermostable DNA polymerase and two primers that are substantially complementary to the target nucleic acid, under conditions such that the target nucleic acid is amplified. The amplified target nucleic acids are then denatured to form single stranded nucleic acids. Following amplification, the sample is subject to a pre-detection incubation step. The sample is incubated for between 1 second and 30 minutes at between 95 DEG C and 120 DEG C to inactivate said polymerization agent. Finally, the presence or absence of the amplified target nucleic acids is determined.
Patent DE-69730232-D1 (DE)
Inventor: COLLINS A
IPC: A61K31/5025
Filed: 1997-01-15
Granted: 2004-09-16
Abstract: Substituted 1-arylphthalazine compositions with the formula wherein R1, R2, R3 and R4 are independently a) H, b) HO, c) R11O-, d) halogen, e) C1-C3-alkyl, f) CF3, g) R12CO2-, or h) R12CONH-; R1 and R2, or R2 and R3, or R3 and R4 can be taken together to be a) -OCH2O-, or b) -OCH2CH2O-; R5 is a) H, b) C1-C6-alkyl, c) C3-C6-alkenyl, d) C3-C6-alkynyl, e) C3-C6-cycloalkyl, f) phenyl or substituted phenyl, wherein the phenyl is substituted with one or two substituents selected from the group consisting of C1-C3-alky, halogen, R12HN-, R12O-, CF3-, R13SO2- and CO2R12, or g) phenyl-C1-C3-alkyl or substituted phenyl-C1-C3-alkyl, wherein the phenyl is substituted with one or two substituents selected from the group consisting of C1-C3-alkyl, halogen, R12HN-, R12O-, CF3-, R13SO2- and -CO2R12; R6 is a) R10R11N-, b) R10NHC(NH)-, c) R12CONH-, d) 1-pyrrolidino or e) 1-piperidino; R7 is H; R8 and R9 are independently a) H, b) C1-C3-alkyl, c) halogen, d) R12O-, e) CF3-, or f) -CO2R12; R10 and R11 are independently a) H, b) C1-C10-alkyl, c) C1-C6-perfluoroalkyl, d) C3-C10-alkenyl, e) C3-C10-alkynyl, or f) C3-C6-cycloalkyl; R12 is H or C1-C3-alkyl; and R13 is C1-C3-alkyl or CF3; and pharmaceutically acceptable salts thereof,
Patent DE-69732208-D1 (DE)
Inventor: OKADA HISASHI
IPC: G03C1/498
Filed: 1997-10-21
Granted: 2005-02-17
Abstract: A photothermographic material contains an organic silver salt, a photosensitive silver halide, a reducing agent, a binder, and a compound of the formula: X-L1-D wherein D is an electron donative group of atoms, X is an adsorption promoting group to silver halide, and L1 is a valence bond or a linking group. It has high sensitivity in the red to infrared region and experiences a minimal change of photographic properties under different developing conditions.
Patent DE-69735284-D1 (DE)
Inventor: YOSHIDA HITOSHI
IPC: H02S40/38
Filed: 1997-12-19
Granted: 2006-04-27
Abstract: A pole (1) incorporating solar cells has a lighting device (5A) or like electric device attached thereto, and a required number of solar cell modules (3) arranged approximately vertically on at least one portion of peripheral wall of the main body of the pole. The arrangement of solar cell modules (3) has the function of generating the electric energy to be consumed by the electric device for one day, utilizing solar radiation afforded by at least scattered sunlight selected from scattered sunlight or direct sunlight. A storage device (4) is provided in the pole main body (2) and has a capacity to accumulate therein the electric energy to be consumed by the electric device for one day, and is repeatedly charged and discharged every day. The pole (1) can be installed in a reduced space, is of all-weather design, operable on clear, rainy or cloudy days, and adjustable in the amount of electric energy to be obtained, and is not limited in the location of installation. The pole is free of failure in charging due to snow in a cold climate and free from droppings of birds, retains satisfactory water-tightness, has an aesthetic appearance and a good balance, and is less likely to fall down owning to the wind or earthquake and excellent in safety.
Patent DE-69735642-D1 (DE)
Inventor: FISCHER E
IPC: A61M37/00
Filed: 1997-01-17
Granted: 2006-05-18
Abstract: A delivery tip for use on a delivery device for applying a dental composition to tooth surfaces includes a tubular member having a proximal end and a distal end. The proximal end of the tubular member is coupled to the delivery device. A plurality of fibrous bristles are disposed on an outer periphery at the distal end of the tubular member. The fibrous bristles can be used in an agitating action to remove entrapped air bubbles from the applied composition such as an impression material. The fibrous bristles on the delivery tip can also be used to coat and spread the composition on tooth surfaces. With the fibrous bristles attached to the outer periphery at the distal end of the delivery tip, the composition can be delivered through the passageway in the tubular member without interference from the bristles.
Patent DE-69807788-D1 (DE)
Inventor: GOMEZ LUIS
IPC: F16K3/02
Filed: 1998-06-26
Granted: 2002-10-17
Abstract: A slide valve includes a housing providing an internal flow passage with which is associated a stationary valve member. A member with an orifice is movable between positions where the orifice is respectively aligned and non-aligned with the flow passage and a plate is secured to the stationary member to prevent the fluid channelling round it. Preferably the housing has a refractory liner within which a protective tube is embedded ; the tube may be metallic and welded to the plate. A purge gas may be introduced into the passage to clean the surfaces of the stationary and movable valve members ; it may be introduced both upstream and downstream of the members. In a modification the tube in the refractory liner is retained but the plate is not essential.
Patent DE-69810600-D1 (DE)
Inventor: VILLAGRAN VALENTINO
IPC: A23F5/40
Filed: 1998-01-26
Granted: 2003-02-13
Abstract: A foamable instant coffee product having a density of at least about 0.4 g/cc and comprising, instant coffee, a densified non-foaming creamer, an acid and a carbonate or bicarbonate salt to generate carbon dioxide, a foaming creamer, a proteinaceous foam stabilizer, and other optional ingredients such as sweeteners, milk solids, flavorants, thickeners, etc. This product is preferably made by compacting the non-foaming creamer, acid, carbonate/bicarbonate salt and instant coffee and then combining this compacted, densified material with the remaining ingredients. Alternatively, this product can be made by compacting the non-foaming creamer, acid and carbonate/bicarbonate salt, extruding the instant coffee and sweetener (e.g., sugar) and then combining the compacted and extruded materials with the remaining ingredients.
Patent DE-69815887-D1 (DE)
Inventor: BOLMSJOE MAGNUS
IPC: A61M31/00
Filed: 1998-12-16
Granted: 2003-07-31
Abstract: Medical device (1) for effecting heat treatment and local delivery of a fluid medicament on body tissue presenting a predetermined section of a boundary wall of a passageway in a human or animal body comprising a catheter-like member (12) for insertion into the passageway to a predetermined insertion position, the catheter-like member being provided with an inflatable balloon structure (11) having a boundary wall which is inflatable against the body tissue when the catheter-like member (12) is in the predetermined insertion position and delivery means (2,11,25) for local delivery of the fluid medicament on the body tissue when the catheter-like member (12) is in the predetermined insertion position, and a heating arrangement (10,15) which is adapted to heat the body tissue when the catheter-like member (12) is in the predetermined insertion position. The delivery means (2,11,25) comprises a supply channel (25) for supply of the fluid medicament to the balloon structure (11) and a construction for the boundary wall (2) of the balloon structure (11) which is permeable to the fluid medicament. Supply of the fluid medicament to the balloon structure along the supply channel (25) when the catheter-like member (12) is in the predetermined insertion position thereby causes the balloon structure (11) to inflate and fluid medicament to be delivered locally on the body tissue through the boundary wall (2) of the balloon structure (11).
Patent DE-69818083-D1 (DE)
Inventor: ARNOLD D
IPC: C07D409/04
Filed: 1998-10-06
Granted: 2003-10-16
Abstract: Chemical compounds that are derivatives of indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole are inhibitors of tyrosine kinase activity. Several of the tyrosine kinases, whose activity is inhibited by these chemical compounds, are involved in hyperproliferative, angiogenic or in vascular hyperpermeability processes. Thus, these chemical compounds can ameliorate disease states where tumor formation, metastasis, angiogenesis, vascular hyperpermeability or endothelial cell proliferation is a factor.
Patent DE-69820634-D1 (DE)
Inventor: BOUCHARD HERVE
IPC: C07D405/06
Filed: 1998-07-15
Granted: 2004-01-29
Abstract: Provided herein are novel polyhydroxyalkylpyrazine derivatives useful in treating and preventing a plethora of diseases including diabetes, having a general formula ofwherein Rc1 represents the chain (II) -CH(OR4)CH(OR3)CH(OR2)CH2OR1 and either Rc2 represents a hydrogen atom and either Rc3 represents the chain (III)-CH2CH(OR6)CH(OR7)CH2OR8 or Rc2 represents the chain (IV)-CH(OR5)CH(OR6)CH(OR7)CH2OR8 or chain (III) -CH2CH(OR6)CH(OR7)CH2OR8 and Rc3 represents a hydrogen atom, and 1 to 8 substituents R1, R2, R3, R4, R5, R6, R7, R8, identical or different, represent a radical independently selected among the radicals a) -COR9, b) -COOR10, c) -CR11R12OCOR13, d) -CR11R12OR13, e) -CONR14R15, and f) one or more pairs of the substituents R1, R2, R3, R4, R6, R7, R8, consecutive or separated by one of the other substituents R2, R3, R6, R7 can also form a group: -C(O)-; the other substituents R1, R2, R3, R4, R6, R7, R8 are hydrogen atoms.
Patent DE-69828057-D1 (DE)
Inventor: LAMBERT NIGEL
IPC: B05D3/06
Filed: 1998-07-03
Granted: 2005-01-13
Abstract: A method of coating a substrate comprises the steps of applying a coating composition to selected areas of the substrate. The coating composition comprises a mixture including at least a reactive part. The reactive part comprises between 30% and 100% multi-functional material, and is photoinitiator free. The coated substrate is exposed, in a curing zone, to ultra-violet light from at least one lamp which has a power output of at least 140 watts per linear centimeter. The ultra-violet light initiates curing of the coating. A substantially inert atmosphere is maintained in the curing zone where the substrate is exposed to the ultra-violet light.